USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER

• 收藏
• 分享

专利权人:

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

发明人:

JUNE, CARL, H.,LEVINE, BRUCE, L.,PORTER, DAVID, L.,KALOS, MICHAEL, D.,MILONE, MICHAEL, C.

申请号：

SG2013043229

公开号：

SG190997A1

申请日:

2011.12.09

申请国别(地区):

SG

年份:

2013

代理人:

摘要：

The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/